Compare PALI & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | NPCT |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.2M | 286.7M |
| IPO Year | 2019 | N/A |
| Metric | PALI | NPCT |
|---|---|---|
| Price | $1.16 | $9.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $9.80 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 89.7K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $1.10 | $8.86 |
| 52 Week High | $2.86 | $10.82 |
| Indicator | PALI | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 29.31 | 47.30 |
| Support Level | N/A | $8.86 |
| Resistance Level | $2.19 | $9.86 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 9.40 | 91.30 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income.